3[2]Fullard JF.The role of the platelet glycoprotein Ⅱb/Ⅲa in thrombosis and haemostasis[J].Curr Pharm Des,2004,10(14):1567-1576. 被引量：1
4[3]Toogeh G,Sharifian R,Lak M,et al.Presentation and pattern of symptoms in 382 patients with Glanzmann thrombasthenia in Iran[J].Am J Hematol,2004,77(2):198-199. 被引量：1
5[4]George JN,Caen JP,Nurden AT.Glanzmann's thrombasthenia:the spectrum of clinical disease[J].Blood,1990,75(7):1383-1395. 被引量：1
6[5]Boudreaux MK,Lipscomb DL.Clinical,biochemical,and molecular aspects of Glanzmann's thrombasthenia in humans and dogs[J].Vet Pathol,2001,38(3):249-260. 被引量：1
7[6]Siddiqui MA,Scott LJ.Recombinant factor Ⅶa (Eptacog Alfa):a review of its use in congenital or acquired haemophilia and other congenital bleeding disorders [J].Drug,2005,65(8):1161-1177. 被引量：1
8[7]Poon MC,D'Oiron R,Von Depka M,et al.Prophylactic and therapeutic recombinant factor Ⅶa administration to patients with Glanzmann's thrombasthenia:results of an international survey[J].J Thromb Haemost,2004,2(7):1096-1103. 被引量：1
9[8]Flood VH,Johnson FL,Boshkov LK,et al.Sustained engraftment post bone marrow transplant despite antiplatelet antibodies in Glanzmann thrombasthenia[J].Pediatr Blood Cancer,2005,45(7):971-975. 被引量：1
10[9]Fang J,Hodivala-Dilke K,Johnson BD,et al.Therapeutic expression of the platelet-specific integrin,alphaⅡbbeta3,in a murine model for Glanzmann thrombasthenia[J].Blood,2005,106(8):2671-2679. 被引量：1
